A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) C07K 16/28 (2006.01) C07K 16/32 (2006.01)
Patent
CA 2415100
A combination antibody therapy for treating B cell malignancies using an immunoregulatory antibody, especially an anti-B7, anti-CD23, or anti-CD40L antibody and a B cell depleting antibody, especially anti-CD19, anti-CD20, anti-CD22 or anti-CD37 antibody is provided. Preferably, the combination therapy will comprise anti-B7 and anti-CD20 antibody administration.
L'invention concerne une thérapie combinée d'anticorps destinée au traitement de malignités des cellules B au moyen d'un anticorps immunorégulateur, notamment un anticorps anti-B7, anti-CD23, ou anti-CD40L et d'un anticorps à action déplétive sur les cellules B, notamment un anticorps anti-CD19, anti-CD20, anti-CD22 ou anti-CD37. La thérapie combinée comprend, de préférence, une administration d'anticorps anti-B7 et anti-CD20.
Hanna Nabil
Hariharan Kandasamy
Biogen Idec Inc.
Gowling Lafleur Henderson Llp
Idec Pharmaceutical Corporation
LandOfFree
Treatment of b cell malignancies using combination of b cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of b cell malignancies using combination of b cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of b cell malignancies using combination of b cell... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1485029